Login
$NEUP
$3.39 +$0.01 (0.3%) Close

Ownership

13F as of Q2 2026 · 5.4M shares outstanding

Who owns NEUP?

By type of holder
Institutions 36.9% Insiders 0.0% Everyone else 63.2%
Concentration Top 10 holders own 35.4%
Lynx1 Capital Management LP 16.2% · AdvisorShares Investments LLC 4.7%
Institutional ownership
36.9%
+4.4 pts vs last qtr
Institutional holders
22
+3 vs last qtr
Net shares bought
+236.1K
by institutions in Q2 2026
New / sold out
6 / 3
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • AdvisorShares Investments LLC +97.5K
  • Vanguard Capital Management LLC +75.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Squadron Capital Management LLC SOLD OUT −76.7K
  • Virtu Financial LLC SOLD OUT −12.0K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Neuphoria Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2026
+498.6%
+81.57% a year
Each share's claim on the business
−83.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.68M
over 4 fiscal years
Diluted shares, split-adjusted
712.3K2.6M4.4M2023: 734.4K shares'232024: 832.2K shares'242025: 1.6M shares'252026: 4.4M shares'26
Buybacks Stock-based comp
$0$672.7K$1.3M2023 buybacks: $02023 stock comp: $1.3M'232024 buybacks: $02024 stock comp: $814.8K'242025 buybacks: $02025 stock comp: $163.8K'252026 buybacks: $02026 stock comp: $351.6K'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years13% Under 1 year87%
Quarterly turnover
11.9%
of institutional shares changed hands
Top 10 managers, median time held
2 quarters

Super Investors

Investment managers reporting NEUP on Form 13F
LC
Lynx1 Capital Management LP
13D · 16.3%
Shares
875.3K
% of company
16.18%
Change vs last qtr
Unchanged
Held since
Q4 '25
AI
AdvisorShares Investments LLC
Shares
252.9K
% of company
4.67%
Change vs last qtr
+97.5K (+62.8%)
Held since
2025

23 more super investors behind a free account

See every manager holding Neuphoria Therapeutics Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting NEUP on Form N-PORT; together they hold 8.9% of the company
AP
AdvisorShares Trust
Position value
$1.11M
% of company
4.67%
% of the fund
2.49%
As of
June 30, 2026
VT
Position value
$481K
% of company
2.04%
% of the fund
0.00%
As of
June 30, 2026

5 more funds behind a free account

See every fund holding Neuphoria Therapeutics Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
CA
Christian Angermayer
5%+ holder13D · 4.5%
Shares
72.6K
% of company
1.34%
Change vs last qtr
—
Held since
—
AI
Apeiron Investment Group Ltd.
5%+ holder13D · 4.5%
Shares
72.6K
% of company
1.34%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support